<![CDATA[Cellagen Technology: New Products - PLK/Aurora]]> https://www.cellagentech.com Tue, 06 Oct 2026 03:22:07 +0000 <![CDATA[VX-680 (Tozasertib) | Aurora A inhibitor]]> https://www.cellagentech.com/vx-680-tozasertib/ Wed, 13 Mar 2013 13:49:44 +0000 https://www.cellagentech.com/vx-680-tozasertib/ VX-680 (Tozasertib), 400x400px, png

VX-680 (Tozasertib) is a small molecule Aurora kinase inhibitor (Aurora-A ~0.6nM, Aurora-B ~18nM, Aurora-C ~4.6nM). VX-680 inhibits cell cycle progression, induces apoptosis and blocks tumor growth in varieties of in vivo xenograft models, including leukemia, colon and pancreatic tumors.

Price: $69.00

]]> VX-680 (Tozasertib), 400x400px, png

VX-680 (Tozasertib) is a small molecule Aurora kinase inhibitor (Aurora-A ~0.6nM, Aurora-B ~18nM, Aurora-C ~4.6nM). VX-680 inhibits cell cycle progression, induces apoptosis and blocks tumor growth in varieties of in vivo xenograft models, including leukemia, colon and pancreatic tumors.

Price: $69.00

]]> VX-680 (Tozasertib) is a small molecule Aurora kinase inhibitor (Aurora-A ~0.6nM, Aurora-B ~18nM, Aurora-C ~4.6nM). VX-680 inhibits cell cycle progression, induces apoptosis and blocks tumor growth in varieties of in vivo xenograft models, including leukemia, colon and pancreatic tumors.

 <![CDATA[BX795 | PDK1/TBK1 inhibitor]]> https://www.cellagentech.com/BX795/ Wed, 13 Mar 2013 00:24:26 +0000 https://www.cellagentech.com/BX795/ BX795, 400x400px, png

BX-795 is an aminopyrimidine-based, ATP-competitive inhibitor of PDK1, TBK1, and IKKe, with IC50 values of 11 nM, 6 nM, and 41 nM, respectively. [1, 2&91; BX-795 also potently inhibits ERK8, MNK2, Aurora B, Aurora C, and MARK3. [3&91; BX-795 inhibits both Thr308-Akt and Thr389-S6K1 phosphorylation at..

Price: $109.00

]]> BX795, 400x400px, png

BX-795 is an aminopyrimidine-based, ATP-competitive inhibitor of PDK1, TBK1, and IKKe, with IC50 values of 11 nM, 6 nM, and 41 nM, respectively. [1, 2&91; BX-795 also potently inhibits ERK8, MNK2, Aurora B, Aurora C, and MARK3. [3&91; BX-795 inhibits both Thr308-Akt and Thr389-S6K1 phosphorylation at..

Price: $109.00

]]> BX-795 is an aminopyrimidine-based, ATP-competitive inhibitor of PDK1, TBK1, and IKKe, with IC50 values of 11 nM, 6 nM, and 41 nM, respectively. [1, 2&91; BX-795 also potently inhibits ERK8, MNK2, Aurora B, Aurora C, and MARK3. [3&91; BX-795 inhibits both Thr308-Akt and Thr389-S6K1 phosphorylation at..]]>